Zona Pellucida Glycoprotein 3 Antikörper

Produktnummer ABIN5701457

Produktdetails anti-Zona Pellucida Glycoprotein 3 Antikörper

Target: Zona Pellucida Glycoprotein 3 (ZP3)

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Zona Pellucida Glycoprotein 3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Immunogen: zona pellucida glycoprotein 3 (sperm receptor)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB:1:200-1:2000,IP:1:200-1:2000,IHC:1:20-1:200

Kommentare:

Recombinant proteins were subjected to SDS PAGE followed by western blot with FNab09753( ZP3 Antibody) at dilution of 1:500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol  pH 7.3

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freeze / thaw cycles.

Lagerung: -20 °C

Haltbarkeit: 12 months

Details zu Zona Pellucida Glycoprotein 3

Target: Zona Pellucida Glycoprotein 3 (ZP3)

Andere Bezeichnung: ZP3 (ZP3 Produkte)

Synonyme: ZP3A antikoerper, ZP3B antikoerper, ZPC antikoerper, Zp-3 antikoerper, zp3.2 antikoerper, Zp-3B antikoerper, zona pellucida glycoprotein 3 antikoerper, zona pellucida sperm-binding protein 3 antikoerper, ZP3 antikoerper, zp3 antikoerper, Zp3 antikoerper

Hintergrund: Synonyms:Sperm receptor, Zona pellucida glycoprotein 3, Zona pellucida protein C, Zp 3, ZP3, ZP3A, ZP3A/ZP3B, ZP3B, ZPC Background:The mammalian zona pellucida, which mediates species-specific sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy, is composed of three to four glycoproteins, ZP1, ZP2, ZP3, and ZP4. ZP3 is essential for sperm binding and zona matrix formation.

Molekulargewicht: 134kDa,observed 150kDa

Gen-ID: 7784

UniProt: P21754

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process